Next-generation sequencing based detection of HER2 copy number predicts pathological response to neoadjuvant therapy in HER2 positive breast cancer

被引：0
|
作者：
Dai, Hao
Jiao, Dechuang
Guo, Xuhui
Qiao, Jianghua
Li, Anfang
Lu, Zhenduo
Chen, Xiuchun
Wang, Chengzheng
Yan, Min
Liu, Zhenzhen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6439
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer
    Xia, Daniel
    Kuo, Frank
    Hughes, Melissa
    Lindeman, Neal
    Manning, Danielle
    Files, Janet
    Strauss, Sarah
    Kirkner, Greg
    Mohammed-Abreu, Ayesha
    Winer, Eric
    Tolaney, Sara M.
    Lin, Nancy U.
    Dillon, Deborah A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (05) : 436 - 442
  • [2] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    Cancer Cell International, 22
  • [3] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [4] HER2 copy number variation detected by next-generation sequencing reveals HER2 expression heterogeneity in gastric cancer.
    Zhang, Xiaotian
    Chen, Hui
    Zhao, Xiaochen
    Wang, Jie
    Bai, Yuezong
    CANCER RESEARCH, 2021, 81 (13)
  • [5] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [6] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [7] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [8] Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
    Niu, Dongfeng
    Li, Lei
    Yu, Yang
    Zang, Wanchun
    Li, Zhongwu
    Zhou, Lixin
    Jia, Ling
    Rao, Guanhua
    Gao, Lianju
    Cheng, Gang
    Ji, Ke
    Lin, Dongmei
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2577 - 2585
  • [9] Predictive Biomarker of Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [10] The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
    Lillemoe, T. J.
    Susnik, B.
    Grimm, E.
    Kang, S-H L.
    Swenson, K. K.
    Krueger, J. L.
    Finkelstein, M. J.
    Tsai, M. L.
    CANCER RESEARCH, 2017, 77
12345